ENT Devices – Market Insights – Japan

The Japanese ENT device market was severely impacted by the COVID-19 pandemic in 2020, but it has since shown significant recovery and is anticipated to return to prepandemic trends in the coming years. Growth over the forecast period will be driven mainly by rising FESS procedure volumes and increasing adoption of innovative and premium-priced products, such as flexiblescopes and powered instruments; conversely, the hand instrument market will be the slowest-growing segment due to the mature nature of the market and a lack of innovation.

This Medtech 360 Report provides comprehensive data and analysis on the state of the ENT device market in Japan from 2019 through 2032.

The COVID-19 pandemic has affected the ENT device market.

To what extent has the COVID-19 pandemic impacted the ENT device market in Japan?

What has been the extent of recovery to date, and when is full recovery expected?

How have capital equipment sales been impacted, and when will they recover?

Most segments in the Japanese ENT device market are mature.

Which procedure types will see the greatest growth through 2032? What factors will drive this growth?

What are the factors hampering the growth of some procedures?

What do medical practitioners predict regarding the current and future landscape of procedures and their related devices?

The adoption of premium-priced products is driving growth in the Japanese ENT device market.

In which device segments are premium-priced products available?

Which products will see increasing physician adoption during the forecast period?

Table of contents